A Study on the Development Strategy for the Prevention of Infectious Diseases in China

Lanjuan Li; Boli Zhang; Jianguo Xu; Weibo Du; Yonghong Xiao; Weihang Ma; Jianzhong Zhang; Junhua Zhang

doi:10.15302/J-SSCAE-2017.02.006

PDF(284 KB)

Strategic Study of CAE ›› 2017, Vol. 19 ›› Issue (2) : 37-42. DOI: 10.15302/J-SSCAE-2017.02.006

Comprehensive Study

A Study on the Development Strategy for the Prevention of Infectious Diseases in China

Author information +

History +

Abstract

To promote and preserve social harmony, social stability, and sustainable economic development, it is essential to carry out a study on the current development strategy for the prevention of infectious diseases in China. It is also necessary to propose a regulatory system and a prevention-and-control research strategy for infectious diseases that are adaptable to China’s specific national conditions. This paper analyzes the epidemic situation and the prevention and control of infectious diseases in China, and systematically expounds the significance of carrying out a study on the development strategy for the prevention of infectious diseases. Using international experience as a reference, this paper proposes strategic measures and suggestions for a regulatory system and for prevention-and-control research into infectious diseases in China. This study is based on China’s achievements and challenges of the current system.

Keywords

infectious diseases / regulatory system / prevention-and-control research / strategic suggestion

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Lanjuan Li, Boli Zhang, Jianguo Xu, Weibo Du, Yonghong Xiao, Weihang Ma, Jianzhong Zhang, Junhua Zhang. A Study on the Development Strategy for the Prevention of Infectious Diseases in China. Strategic Study of CAE, 2017, 19(2): 37‒42 https://doi.org/10.15302/J-SSCAE-2017.02.006

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	李兰娟. 我国感染病的现状及防治策略 [J]. 中华临床感染病杂志, 2008, 1(1): 1–6.

[2]	World Health Organization. The top 10 cause of death [R]. Geneva: World Health Organization, 2014.

[3]	樊新民. 我国艾滋病传播的现状与对策 [J]. 求实, 2014 (A01): 190–192.

[4]	World Health Organization. Antimicrobial resistance: Global report on surveillance [R]. Geneva: World Health Organization, 2014.

[5]	Center for Disease Control. Antibiotic resistance threat in US [R]. Altlantic: Center for Disease Control, 2013.

[6]	肖永红, 沈萍, 魏泽庆, 等. Mohnarin 2011年度全国细菌耐药监测 [J]. 中华医院感染学杂志, 2012, 22(22): 4946–4952.

[7]	高海女, 姚航平, 杨仕贵, 等. 从 SARS 到 MERS：证据与展望 [J]. 中华临床感染病杂志, 2015, 8(4): 292–298.

[8]	王明亮, 孙静, 王亚东, 等. 以情景构建为基础的美国应急预案体系建设对我国应急管理的启示 [J]. 医学教育管理, 2016, 2(2): 458–463.

[9]	文朝阳, 王雅梅, 杨晓梅，等. 以医学教育国际认证为契机探索建立生物化学全程素质考核系统 [J]. 基础医学与临床, 2015, 35(2): 278–280.

[10]	Silva C J, Torres D F M. Optimal control for a tuberculosis model with reinfection and post-exposure interventions [J]. Mathematical Biosciences, 2013, 244(2): 154–164.

[11]	Laxminarayan R, Sridhar D, Blaser M, et al. Achieving global targets for antimicrobial resistance [J]. Science, 2016, 353(6302): 874–875.

[12]	Soothill G, Hu Y, Coates A. Can we prevent antimicrobial resis-tance by using Antimicrobials better? [J]. Pathogens, 2013, 2(2): 422–435.

[13]	World Health Organization. Global tuberculosis control: Epidemi-ology, strategy, financing [R]. Geneva: World Health Organization, 2009.

[14]	连建奇, 王九平, 张久聪. 传染病学教学模式的创新与探索 [J].西北医学教育, 2009, 17(3): 608–610.

[15]	Anya I, Ihekweazu C. Democracy in Nigeria: The challenge of infectious disease control [J]. Journal of Infection in Developing Countries, 2008, 2(2): 151–153.